Bharat Immunologicals & Biologicals Corporation Balance Sheet Annual

BSE: 524663 | NSE: - | ISIN: INE994B01014 | Sector: Major Drugs

23.63 +0.01 (0.04%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2023	2022	2021	2020
Period End Date	Mar 23	Mar 22	Mar 21	Mar 20
Cash	7.45	8.37	9.31	11.11
Cash Equivalents	1.29	4.64	1.23	0.99
Cashand Short Term Investments	8.74	13.01	10.54	12.10
Accounts Receivable- Trade Net	13.88	1.13	0.01	17.61
Total Receivables Net	13.88	1.13	0.01	17.61
Total Inventory	1.43	36.25	13.49	51.72
Other Current Assets Total	9.02	15.04	9.92	11.59
Total Current Assets	33.06	65.43	33.95	93.02
Property/ Plant/ Equipment Total- Net	115.33	115.98	36.13	4.68
Long Term Investments	9.28	9.06	12.52	13.63
Note Receivable- Long Term	0.71	0.78	0.85	0.98
Other Long Term Assets Total	27.27	21.48	20.54	14.51
Total Assets	185.66	212.73	103.99	126.83
Accounts Payable	0.48	0.87	14.79	43.53
Notes Payable/ Short Term Debt	70.22	77.89	27.29	3.04
Other Currentliabilities Total	20.74	22.51	22.00	54.14
Total Current Liabilities	91.44	101.26	64.09	100.71
Total Debt	70.22	77.89	27.29	3.04
Other Liabilities Total	6.42	6.11	5.85	5.65
Total Liabilities	97.86	107.38	69.94	106.36
Common Stock Total	43.18	43.18	43.18	43.18
Retained Earnings( Accumulated Deficit)	44.62	62.17	-9.14	-22.71
Total Equity	87.80	105.35	34.04	20.47
Total Liabilities Shareholders' Equity	185.66	212.73	103.99	126.83
Total Common Shares Outstanding	4.32	4.32	4.32	4.32
Tangible Book Valueper Share Common Eq	20.33	24.40	7.88	4.74
Total Long Term Debt	-	0.00	0.00	0.00